NEW YORK (GenomeWeb) – Singapore-based cancer detection firm Ark said today that it has raised $40 million in a Series A investment led by shareholders of Venturecraft and backed by Gaorong Capital (formerly Banyan Capital).

The company is the result of a merger between Venturecraft and MiRxes, a technology firm that was spun out of Singapore's Agency for Science, Technology and Research (A*STAR) in 2014.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.